Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Blanca Scheijen"'
Autor:
Madeleine R. Berendsen, Diede A.G. van Bladel, Eva Hesius, Cristina Berganza Irusquieta, Jos Rijntjes, Annemiek B. van Spriel, Ellen van der Spek, Johannes F.M. Pruijt, Leonie I. Kroeze, Konnie M. Hebeda, Sandra Croockewit, Wendy B.C. Stevens, J Han J.M. van Krieken, Patricia J.T.A. Groenen, Michiel van den Brand, Blanca Scheijen
Publikováno v:
HemaSphere, Vol 7, Iss 11, p e976 (2023)
Patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) occasionally develop diffuse large B-cell lymphoma (DLBCL). This mostly results from LPL/WM transformation, although clonally unrelated DLBCL can also arise. LPL/WM is c
Externí odkaz:
https://doaj.org/article/b1eea56b04e64b798ef6fb53b94420e2
Autor:
Miriam Butler, Britt M.T. Vervoort, Dorette S. van Ingen Schenau, Lieneke Jongeneel, Jordy C.G. van der Zwet, René Marke, Jules P.P. Meijerink, Blanca Scheijen, Laurens T. van der Meer, Frank N. van Leeuwen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Although long-term survival in pediatric acute lymphoblastic leukemia (ALL) currently exceeds 90%, some subgroups, defined by specific genomic aberrations, respond poorly to treatment. We previously reported that leukemias harboring deletions or muta
Externí odkaz:
https://doaj.org/article/bd62010cd4ac4cb38d96197bfa9e66ae
Autor:
Elise M. Bekers, Astrid Eijkelenboom, Paul Rombout, Peter van Zwam, Suzanne Mol, Emiel Ruijter, Blanca Scheijen, Uta Flucke
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-10 (2019)
Abstract Background Intramuscular myxoma (IM) is a hypocellular benign soft tissue neoplasm characterized by abundant myxoid stroma and occasional hypercellular areas. These tumors can, especially on biopsy material, be difficult to distinguish from
Externí odkaz:
https://doaj.org/article/07f88e3c24484780a47a1c2e67e4dd72
Autor:
Madeleine R. Berendsen, Diede A.G. van Bladel, Eva Hesius, Fleur A. de Groot, Leonie I. Kroeze, Jos Rijntjes, Jeroen A.C.W. Luijks, Brigiet Hoevenaars, Altuna Halilovic, Peet Nooijen, Esther van Bladel, Susan de Jonge-Peeters, Chantal Lensen, Hans Pruijt, Ellen van der Spek, Joost S.P. Vermaat, Corine Hess, Konnie M. Hebeda, Wendy B.C. Stevens, J. Han J.M. van Krieken, Michiel van den Brand, Patricia J.T.A. Groenen, Blanca Scheijen
Publikováno v:
Modern Pathology, 36
Modern Pathology, 36(5). ELSEVIER SCIENCE INC
Modern Pathology, 36, 5
Modern Pathology, 36(5). ELSEVIER SCIENCE INC
Modern Pathology, 36, 5
Approximately one-third of patients with diffuse large B-cell lymphoma (DLBCL) relapse and often require salvage chemotherapy followed by autologous stem cell transplantation. In most cases, the clonal relationship between the first diagnosis and sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db5e019cdc1fa5d0040d95489fd768a
https://hdl.handle.net/2066/291853
https://hdl.handle.net/2066/291853
Autor:
Eva A M Hesius, Lidia van Laar, Margriet Oosterveld, Annemiek B van Spriel, Blanca Scheijen, Jan Willem Leeuwis, Henri A M Marres, Patricia J T A Groenen, Wendy B C Stevens, Ellen van der Spek, Adriaan J C van den Brule, Brigiet M Hoevenaars, Konnie M Hebeda, Michiel van den Brand
Publikováno v:
Histopathology, 82, 1013-1020
Histopathology, 82, 7, pp. 1013-1020
Histopathology, 82, 7, pp. 1013-1020
Contains fulltext : 292872.pdf (Publisher’s version ) (Open Access) AIMS: Large B cell lymphoma with IRF4 rearrangement (LBCL-IRF4) is a new entity in the 2017 revised World Health Organisation (WHO) classification that was initially mainly reporte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b12dbb1c8fb1526e2b86889278e32a7
http://hdl.handle.net/2066/292872
http://hdl.handle.net/2066/292872
Publikováno v:
Haematologica, Vol 103, Iss 4 (2018)
Transcription factor IKZF1 (IKAROS) acts as a critical regulator of lymphoid differentiation and is frequently deleted or mutated in B-cell precursor acute lymphoblastic leukemia. IKZF1 gene defects are associated with inferior treatment outcome in b
Externí odkaz:
https://doaj.org/article/b8dae7a6aba149109f3f60a37a35a6a0
Autor:
Hesham ElDaly, Nikos Darzentas, Frederic Davi, Michael Hummel, Ioannis Anagnostopoulos, Leonie I. Kroeze, Michiel van den Brand, Tomáš Reigl, Blanca Scheijen, Patricia J. T. A. Groenen, Jakub Paweł Porc, Jos Rijntjes, Falko Fend, Michèle Y. van der Klift, Kim C. Heezen, Julia Steinhilber, Hongxiang Liu, Anton W. Langerak, Markus Möbs, Jeroen A.C.W. Luijks
Publikováno v:
Journal of Molecular Diagnostics
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2021, 23 (9), pp.1105-1115. ⟨10.1016/j.jmoldx.2021.06.005⟩
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2021, 23 (9), pp.1105-1115. ⟨10.1016/j.jmoldx.2021.06.005⟩
Ig gene (IG) clonality analysis has an important role in the distinction of benign and malignant B-cell lymphoid proliferations and is mostly performed with the conventional EuroClonality/BIOMED-2 multiplex PCR protocol and GeneScan fragment size ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4545b37be0e4cf8ccdaf0b83b9215081
https://doi.org/10.1016/j.jmoldx.2021.06.005
https://doi.org/10.1016/j.jmoldx.2021.06.005
Autor:
Blanca Scheijen, Judith M. Boer, René Marke, Esther Tijchon, Dorette van Ingen Schenau, Esmé Waanders, Liesbeth van Emst, Laurens T. van der Meer, Rob Pieters, Gabriele Escherich, Martin A. Horstmann, Edwin Sonneveld, Nicola Venn, Rosemary Sutton, Luciano Dalla-Pozza, Roland P. Kuiper, Peter M. Hoogerbrugge, Monique L. den Boer, Frank N. van Leeuwen
Publikováno v:
Haematologica, Vol 102, Iss 3 (2017)
Deletions and mutations affecting lymphoid transcription factor IKZF1 (IKAROS) are associated with an increased relapse risk and poor outcome in B-cell precursor acute lymphoblastic leukemia. However, additional genetic events may either enhance or n
Externí odkaz:
https://doaj.org/article/4b9e33dbdf0346af888f8b42df273b6a
Autor:
Madeleine Berendsen, Diede van Bladel, Eva Hesius, Fleur de Groot, Leonie Kroeze, Jos Rijntjes, Jeroen Luijks, Brigiet Hoevenaars, Altuna Halilovic, Peet Nooijen, Ellen van der Spek, Joost Vermaat, Corine Hess, Konnie Hebeda, Wendy Stevens, J. Han van Krieken, Michiel van den Brand, Patricia Groenen, Blanca Scheijen
Approximately one-third of diffuse large B-cell lymphoma (DLBCL) patients relapse, who often require salvage chemotherapy followed by autologous stem cell transplantation. In most cases, the clonal relationship between the first diagnosis and subsequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31e756be2f8c110ad51de4572bb9e7e5
https://doi.org/10.21203/rs.3.rs-1862007/v1
https://doi.org/10.21203/rs.3.rs-1862007/v1
Autor:
Suraya Elfrink, Martin ter Beest, Luuk Janssen, Marijke P. Baltissen, Pascal W. T. C. Jansen, Angelique N. Kenyon, Raymond M. Steen, Daynelys de Windt, Philipp M. Hagemann, Corine Hess, Dick-Johan van Spronsen, Brigiet Hoevenaars, Ellen van der Spek, Zijun Y. Xu-Monette, Ken H. Young, Charlotte Kaffa, Sander Bervoets, Jolien van Heek, Eva Hesius, Charlotte M. de Winde, Michiel Vermeulen, Michiel van den Brand, Blanca Scheijen, Annemiek B. van Spriel
Publikováno v:
BLOOD ADVANCES, 6(7), 2254-2266. American Society of Hematology
Blood Advances, 6, 2254-2266
Elfrink, S, ter Beest, M, Janssen, L, Baltissen, M P, Jansen, P W T C, Kenyon, A N, Steen, R M, de Windt, D, Hagemann, P M, Hess, C, van Spronsen, D J, Hoevenaars, B, van der Spek, E, Xu-Monette, Z Y, Young, K H, Kaffa, C, Bervoets, S, van Heek, J, Hesius, E, de Winde, C M, Vermeulen, M, van den Brand, M, Scheijen, B & van Spriel, A B 2022, ' IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma ', BLOOD ADVANCES, vol. 6, no. 7, pp. 2254-2266 . https://doi.org/10.1182/bloodadvances.2021004366
Blood Advances, 6, 7, pp. 2254-2266
Blood Advances, 6, 2254-2266
Elfrink, S, ter Beest, M, Janssen, L, Baltissen, M P, Jansen, P W T C, Kenyon, A N, Steen, R M, de Windt, D, Hagemann, P M, Hess, C, van Spronsen, D J, Hoevenaars, B, van der Spek, E, Xu-Monette, Z Y, Young, K H, Kaffa, C, Bervoets, S, van Heek, J, Hesius, E, de Winde, C M, Vermeulen, M, van den Brand, M, Scheijen, B & van Spriel, A B 2022, ' IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma ', BLOOD ADVANCES, vol. 6, no. 7, pp. 2254-2266 . https://doi.org/10.1182/bloodadvances.2021004366
Blood Advances, 6, 7, pp. 2254-2266
Contains fulltext : 248786.pdf (Publisher’s version ) (Open Access) Diffuse large B-cell lymphoma (DLBCL) represents the most common form of non-Hodgkin lymphoma (NHL) that is still incurable in a large fraction of patients. Tetraspanin CD37 is hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c9362c02409474953d468c7bfab5331
https://research.vumc.nl/en/publications/c5927e2c-91d7-4654-8eb4-2172d145dada
https://research.vumc.nl/en/publications/c5927e2c-91d7-4654-8eb4-2172d145dada